HOME >> BIOLOGY >> NEWS
Alcohol-dependence gene identified

St. Louis, Jan. 14, 2004 -- Investigators at Washington University School of Medicine in St. Louis, Indiana University School of Medicine and other centers have identified a gene that appears to increase the risk of alcoholism.

The study, published in the January issue of the journal Alcoholism: Clinical and Experimental Research, is the first to demonstrate an association between this particular gene and alcohol dependence.

The gene is related to a receptor that allows for the movement of Gamma-amino butyric acid (GABA) between nerve cells. GABA is the major inhibitory chemical in the central nervous system.

"There were lines of evidence from other studies -- animal studies, in vitro studies -- that suggested GABA receptors are involved in the behavioral effects of alcohol," says lead author Danielle M. Dick, Ph.D., research assistant professor of psychiatry at Washington University School of Medicine in St. Louis. "Because GABA receptor genes were likely candidates and previous studies had linked this area on chromosome 15 to alcoholism, we zeroed in on three GABA receptor genes but only found significant association with one of them."

The study was conducted as part of the national Collaborative Study on the Genetics of Alcoholism (COGA), an ongoing project involving interviews and DNA samples from more than 10,000 individuals from inpatient and outpatient alcohol treatment centers and their families. Families in the COGA study usually have several members with alcohol dependence.

For this study, the investigators analyzed DNA from 262 families, a total of 2,282 individuals. They isolated three genes on chromosome 15 -- GABRA5, GABRB3 and GABRG3 -- that sit very close together on the chromosome. Then the investigators used markers called SNPs (single nucleotide polymorphisms) to study differences between the participants' genes.

The markers demonstrated small genetic differences did appear to influence th
'"/>

Contact: Jim Dryden
jdryden@wustl.edu
314-286-0110
Washington University School of Medicine
14-Jan-2004


Page: 1 2

Related biology news :

1. Rare childhood genetic syndrome identified
2. Newly identified master gene key in babys first breath
3. Key stimulator of colorectal cancer identified
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. A probable cause for high blood pressure identified - shows links with diabetes
6. Millennia still mean early days for newly identified sex chromosome
7. Gene associatied with lupus identified
8. Gene linked to cleft lip and palate identified
9. Last of known genes identified in complex obesity syndrome
10. Leukemia stem cells identified by Stanford researchers
11. New prostate cancer gene identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology:
Cached News: